465 related articles for article (PubMed ID: 30287889)
1. Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia.
Yasir M; Ajlan AM; Shakil S; Jiman-Fatani AA; Almasaudi SB; Farman M; Baazeem ZM; Baabdullah R; Alawi M; Al-Abdullah N; Ismaeel NA; Shukri HA; Azhar EI
Sci Rep; 2018 Oct; 8(1):14847. PubMed ID: 30287889
[TBL] [Abstract][Full Text] [Related]
2. First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from Germany.
Valenza G; Werner M; Eisenberger D; Nickel S; Lehner-Reindl V; Höller C; Bogdan C
J Glob Antimicrob Resist; 2019 Jun; 17():305-308. PubMed ID: 30682563
[TBL] [Abstract][Full Text] [Related]
3. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia.
Alyamani EJ; Khiyami AM; Booq RY; Majrashi MA; Bahwerth FS; Rechkina E
Ann Clin Microbiol Antimicrob; 2017 Jan; 16(1):1. PubMed ID: 28061852
[TBL] [Abstract][Full Text] [Related]
4. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Characteristics of Sequence Type 131
Park JY; Yun KW; Choi EH; Lee HJ
Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
[No Abstract] [Full Text] [Related]
6. Phenotypic and genotypic characterization of extended-spectrum b-lactamases producing Escherichia coli and Klebsiella pneumoniaein a tertiary care hospital in Riyadh, Saudi Arabia.
Somily AM; Arshad MZ; Garaween GA; Senok AC
Ann Saudi Med; 2015; 35(6):435-9. PubMed ID: 26657226
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
[TBL] [Abstract][Full Text] [Related]
8. Detection of Escherichia coli Producing CTX-M-1-Group Extended-Spectrum β-Lactamases from Pigs in Aichi Prefecture, Japan, between 2015 and 2016.
Norizuki C; Kawamura K; Wachino JI; Suzuki M; Nagano N; Kondo T; Arakawa Y
Jpn J Infect Dis; 2018 Jan; 71(1):33-38. PubMed ID: 29279444
[TBL] [Abstract][Full Text] [Related]
9. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
Abrar S; Vajeeha A; Ul-Ain N; Riaz S
Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
[TBL] [Abstract][Full Text] [Related]
10. Spread of CTX-Type Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates of Epidemic Clone B2-O25-ST131 Among Dogs and Cats in Japan.
Kawamura K; Sugawara T; Matsuo N; Hayashi K; Norizuki C; Tamai K; Kondo T; Arakawa Y
Microb Drug Resist; 2017 Dec; 23(8):1059-1066. PubMed ID: 28380311
[TBL] [Abstract][Full Text] [Related]
11. High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
Maciuca IE; Williams NJ; Tuchilus C; Dorneanu O; Guguianu E; Carp-Carare C; Rimbu C; Timofte D
Microb Drug Resist; 2015 Dec; 21(6):651-62. PubMed ID: 25734920
[TBL] [Abstract][Full Text] [Related]
12. Molecular diversity of Extended-spectrum β-lactamase-producing Escherichia coli from vultures in Canary Islands.
Carvalho I; Tejedor-Junco MT; González-Martín M; Corbera JA; Suárez-Pérez A; Silva V; Igrejas G; Torres C; Poeta P
Environ Microbiol Rep; 2020 Oct; 12(5):540-547. PubMed ID: 32755023
[TBL] [Abstract][Full Text] [Related]
13. Molecular typing of CTX-M-producing escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients.
Hu YY; Cai JC; Zhou HW; Chi D; Zhang XF; Chen WL; Zhang R; Chen GX
Appl Environ Microbiol; 2013 Oct; 79(19):5988-96. PubMed ID: 23892737
[TBL] [Abstract][Full Text] [Related]
14. Fecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan.
Huang IF; Lee WY; Wang JL; Hung CH; Hu HH; Hung WY; Hung YJ; Chen WC; Shen YT; Cheng MF
BMC Gastroenterol; 2018 Jun; 18(1):86. PubMed ID: 29907090
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of CTX-M-Type Extended-Spectrum β-Lactamase-Producing
Kawamura K; Hayashi K; Matsuo N; Kitaoka K; Kimura K; Wachino JI; Kondo T; Iinuma Y; Murakami N; Fujimoto S; Arakawa Y
Microb Drug Resist; 2018 Dec; 24(10):1513-1520. PubMed ID: 29791251
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic Susceptibilities and Genetic Characteristics of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates from Stools of Pediatric Diarrhea Patients in Surabaya, Indonesia.
Bagus Wasito E; Shigemura K; Osawa K; Fardah A; Kanaida A; Raharjo D; Kuntaman K; Hadi U; Harijono S; Marto Sudarmo S; Nakamura T; Shibayama K; Fujisawa M; Shirakawa T
Jpn J Infect Dis; 2017 Jul; 70(4):378-382. PubMed ID: 28003592
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of Escherichia coli producing extended-spectrum β-lactamase CTX-M-14 and CTX-M-28 in Mexico.
Silva-Sánchez J; Duran-Bedolla J; Lozano L; Reyna-Flores F; ; Barrios-Camacho H
Braz J Microbiol; 2024 Mar; 55(1):309-314. PubMed ID: 37978118
[TBL] [Abstract][Full Text] [Related]
19. Genomic and antimicrobial resistance genes diversity in multidrug-resistant CTX-M-positive isolates of Escherichia coli at a health care facility in Jeddah.
Yasir M; Farman M; Shah MW; Jiman-Fatani AA; Othman NA; Almasaudi SB; Alawi M; Shakil S; Al-Abdullah N; Ismaeel NA; Azhar EI
J Infect Public Health; 2020 Jan; 13(1):94-100. PubMed ID: 31279801
[TBL] [Abstract][Full Text] [Related]
20. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals.
Zhang J; Zheng B; Zhao L; Wei Z; Ji J; Li L; Xiao Y
BMC Infect Dis; 2014 Dec; 14():659. PubMed ID: 25466590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
